Christopher Loh

Christopher Loh

Christopher Loh is a partner in Venable Fitzpatrick’s Intellectual Property Litigation Practice in New York. He practices complex patent litigation in the areas of pharmaceuticals, biotechnology, and chemistry. As lead or co-counsel, Chris has litigated patent cases involving oncology therapies, anti-HIV therapies, anti-hepatitis drugs, antidepressants, and statins. He has argued before numerous federal district courts and the United States Court of Appeals for the Federal Circuit, and has won in inter partes review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB), on behalf of patent owners.

For more information or to contact Christopher, please visit his Firm Profile Page.


Posts by Christopher Loh


New Dance Moves? Purple Book Amendments Require Public Disclosure of ‘Patent Dance’ Patent Lists

Innovator (or “reference”) biologic drug makers and small-molecule drug makers face differing legal obligations with respect to public patent disclosures. Under the Hatch-Waxman Act, reference small-molecule drug …
By Christopher Loh
2 months ago 0

PTAB Establishes Two-Part Framework for Denying Institution of IPRs Based on Previously Presented Art Or Argument

Earlier this year, the Patent Trial and Appeal Board (PTAB) established a two-part framework for applying 35 U.S.C. § 325(d), under which the PTAB may deny institution …
By Christopher Loh
1 year ago 3